Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

Trump DOJ investigating Biden-era pardons amid concerns over state of mind

by admin June 3, 2025
June 3, 2025
Trump DOJ investigating Biden-era pardons amid concerns over state of mind
NEWYou can now listen to Fox News articles!

President Donald Trump’s Justice Department is reviewing the list of people that were granted pardons by former President Joe Biden, amid new concerns about his use of an AutoPen to automatically sign documents, as well as concerns about his state of mind in his final months in office.

Fox News was told Tuesday that Justice Department Pardon Attorney Ed Martin is reviewing a list of Biden-era pardons granted by the president during his final weeks in office.

It is unclear what individual pardons are being reviewed by Martin’s office, though Reuters reported this week that the office is planning to look at the preemptive pardons that Biden granted to his son, Hunter Biden, as well as more than 35 death row inmates whose sentences were changed to life in prison during Biden’s final days in office. 

DOJ officials did not respond to Fox News’s requests for comments on the email or the exact nature of the review

Former President Joe Biden used his final weeks as commander-in-chief to grant clemency and pardon more than 1,500 individuals, in what the White House described at the time as the largest single-day act of clemency by a U.S. president.

But critics took umbrage at the long list of names, noting that it included persons convicted of defrauding U.S. taxpayers of tens of millions of dollars. Many took aim at his use of preemptive pardons to family members and others in Biden’s inner circle.

This is a developing news story. Check back for updates.

This post appeared first on FOX NEWS

previous post
FBI calls for public tips on children hurt in ‘gender-affirming’ surgeries
next post
LIZ PEEK: Trump must stay strong, US reliance on Chinese minerals and drugs puts Americans at risk

related articles

Biden approves $500M Ukraine security package 11 days...

January 9, 2025

If Republicans were telling the truth about supporting...

January 22, 2025

Top House Dem exposes party’s strategy to blame...

September 25, 2025

‘It’s absurd’: DHS shutdown bears down on US...

February 14, 2026

Biden defends controversial autopen use for mass clemency...

July 14, 2025

How closed-door negotiations and a guarantee ended longest...

November 15, 2025

Who could lead if Zelenskyy resigned?

March 1, 2025

White House says 9th telecoms company has been...

December 28, 2024

Morning Glory: Change comes to the White House...

February 27, 2025

Europe must invoke ‘snapback’ sanctions on Iran, US...

February 14, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 4

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,600)
    • Stocks (1,442)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved